Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Quantification in simultaneous (99m)Tc/(123)I brain SPECT using generalized spectral factor analysis: a Monte Carlo

Sebastien Hapdey1, Marine Soret, Irene Buvat

  • 1Centre Henri Becquerel - Rouen University Hospital and QuantIF Laboratory, Rouen, France.

Physics in Medicine and Biology
|November 18, 2006
PubMed
Summary

Generalized spectral factor analysis (GSFA) effectively corrects crosstalk in simultaneous technetium-99m/iodine-123 (99mTc/123I) SPECT imaging. This method significantly improves quantitative accuracy for brain SPECT, matching gold standard performance.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Automatic lesion segmentation in ⁶⁸Ga-PSMA PET/CT and ¹⁷⁷Lu-PSMA SPECT/CT: added value of PET-guided SPECT in a bicentric study.

EJNMMI research·2026
Same author

Brain Metabolic Activity Measured by [<sup>18</sup>F]FDG PET/CT Predicts Survival in Patients with Advanced Non-Small Cell Lung Cancer.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same author

Cross-disciplinary methodologies for whole-person research - insights from EMPOWER2024.

Npj imaging·2026
Same author

CMV seropositivity associates with poor clinical outcome in triple negative breast cancer.

iScience·2026
Same author

Prognostic value of TMTV and Dmax calculated from <sup>18</sup>F-fluorodeoxyglucose positron emission tomography images in metastatic cutaneous melanoma treated with immune checkpoint blockade.

European journal of nuclear medicine and molecular imaging·2026
Same author

Toward genomic personalization of breast cancer radiotherapy: foundations, challenges, and a roadmap for clinical integration.

Breast (Edinburgh, Scotland)·2026

Area of Science:

  • Nuclear Medicine
  • Medical Imaging
  • Radiochemistry

Background:

  • Simultaneous SPECT imaging with 99mTc and 123I allows for direct comparison of radiotracer distribution in identical physiological states.
  • Image distortion due to isotopic cross-talk is a significant challenge in simultaneous 99mTc/123I SPECT acquisitions.
  • Existing spectral window methods often result in substantial quantitative inaccuracies.

Purpose of the Study:

  • To introduce and evaluate a generalized spectral factor analysis (GSFA) method for mitigating cross-talk in simultaneous 99mTc/123I SPECT.
  • To assess the quantitative accuracy of GSFA compared to conventional spectral window methods and a gold standard.

Main Methods:

  • GSFA models the energy spectrum in each pixel as a linear combination of basis spectra (99mTc photopeak, 123I photopeak, and scatter).

Related Experiment Videos

  • Basis spectra are estimated using factor analysis incorporating physical priors like Klein-Nishina distributions.
  • The method was validated using Monte Carlo simulated 99mTc/123I SPECT data.
  • Main Results:

    • GSFA demonstrated significantly improved quantitative accuracy compared to the conventional spectral window (WIN) method.
    • Activity concentration differences with GSFA were less than 9% compared to gold standard (GS) values.
    • WIN method showed large differences, ranging from -23% to 110% for 123I and 99mTc images, respectively.

    Conclusions:

    • GSFA effectively solves the cross-talk issue in simultaneous 99mTc/123I SPECT imaging.
    • The GSFA method enables quantitative accuracy comparable to sequential, scatter-free imaging for brain SPECT.
    • This advancement facilitates more reliable dual-isotope SPECT studies in clinical applications.